100% French Stocks – December 17, 2025

PREOPEN CAC 40: 8,134 points (+0.26%)

Key Stocks of the Day

Sanofi (SAN): Its drug Efdoralprin receives orphan drug designation from the European Medicines Agency (EMA).

Pernod Ricard (RI): Announces the sale of Mumm Napa sparkling wines to Trinchero; definitive agreement reached.

DBV Technologies (DBV): Successful clinical trial for its peanut allergy treatment. FDA marketing application planned.

Vinci (DG): Highway traffic declined in November, but notable rise (+5.9%) at airports.

Airports of Paris (ADP): Strong passenger traffic growth in November (+5.9%).

Euroapi (EAPI): Expects a greater drop in revenue in 2025.

Plastivaloire (PVL): Forecasts a slight revenue decline for 2025-2026.

Abionyx (ABNX): Launching a €1.8M capital increase to fund development through 2026.

Implanet (ALIMP): First surgeries performed in China with its JAZZ system.

Voltalia (VLTSA): Launches the construction of a hybrid solar power plant in French Guiana.

Crédit Agricole (ACA): Éric Vial elected chairman of the board.

Bic (BB): Karen Guerra appointed to the board to replace Carole Callebaut Piwnica.

(No major results reported at this time)

DBV Technologies (DBV)

→ Cantor Fitzgerald remains at overweight, target raised from USD 42 to 48.

→ Guggenheim remains at buy, target raised from USD 35 to 51.

Abivax (ABVX)

→ Leerink Partners remains at outperform, target raised from USD 115 to 138.

→ Piper Sandler remains at overweight, target raised from USD 112 to 142.

Eurofins Scientific (ERF)
→ Bernstein remains at outperform, target adjusted to EUR 72.30.

Arkema (AKE)

→ UBS maintains buy but cuts target from EUR 70 to 64.

Airports of Paris (ADP)

→ Jefferies moves from buy to hold, despite a raised target of EUR 134.

Pernod Ricard (RI)

→ Deutsche Bank remains at hold, target reduced from EUR 80 to 75.

→ Morgan Stanley remains at underweight, target reduced from EUR 84 to 80.

Sartorius Stedim Biotech (DIM)

→ Bernstein remains at outperform, target slightly reduced from EUR 248 to 245.

Solvay (SOLB)

→ UBS remains at neutral, target adjusted to EUR 28.

No major downgrades reported for French stocks this morning.